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Abstract
Background:  The anti-inflammatory effects of proanthocyanidins (PACs), isolated from
blackcurrant (Ribes nigrum L.) leaves, were analysed using carrageenin-induced paw oedema and
carrageenin-induced pleurisy in rats.
Results: Pretreatment of the animals with PACs (10, 30, 60 and 100 mg/kg, i.p.) reduced paw
oedema induced by carrageenin in a dose and time-dependent manner. PACs also inhibited dose-
dependently carrageenin-induced pleurisy in rats. They reduced (A) lung injury, (B) pleural exudate
formation, (C) polymorphonuclear cell infiltration, (D) pleural exudate levels of TNF-α, IL-1β and
CINC-1 but did not affect IL-6 and IL-10 levels. They reduced (E) pleural exudate levels of nitrite/
nitrate (NOx). In indomethacin treated rats, the volume of pleural exudate was low, its content in
leukocytes and its contents in TNF-α, IL-1β, IL-6 and IL-10 but not in NOx were reduced. These
data suggest that the anti-inflammatory properties of PACs are achieved through a different pattern
from those of indomethacin.
Conclusion: These results suggest that the main mechanism of the anti-inflammatory effect of
PACs mainly lies in an interference with the migration of the leukocytes. Moreover, PACs inhibited
in vivo nitric oxide release.
Background
Proanthocyanidins are compounds, naturally occurring in
various plants, with anti-inflammatory [1,2] and anti-
arthritic activities [3]. They are reported to prevent skin
aging and heart diseases, they scavenge oxygen free radi-
cals and inhibit UV radiation-induced peroxidation [4-
10].
We have isolated prodelphinidins and procyanidins,
proanthocyanidins (PACs) from blackcurrant (Ribes
nigrum L., Grossulariaceae) leaves which are used in Euro-
pean traditional medicine for the treatment of inflamma-
tory disorders such as rheumatic diseases [11]. Majority of
these compounds are water soluble monomers and oli-
gomers (2 to 3 units) consisting of flavan 3-ol monomer
units linked together by mostly C-4 to C-8 (Figure 1) and
to a lesser extent C-4 to C-6 bindings. Few tetramers are
also found.
Previously, we have observed that, in vitro, these com-
pounds profoundly affect the metabolism of chondro-
cytes : they increase the secretion from these cells of type
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II collagen and proteoglycans while they decrease the
secretion of prostaglandin E2 (PGE2) [12]. On the other
hand, while these compounds inhibited purified cyclo-
oxygenase-1 and cyclo-oxygenase-2, they did not reduce
the release of thromboxane B2 and PGE2 from human in
vitro stimulated platelets and neutrophils respectively
[12]. Moreover, PACs might influence the contractile sta-
tus of smooth muscles of blood vessels : intravenous and
intraperitoneal injection of PACs induced a drop of the
blood pressure without a significant bradycardia [13].
This effect counteracts the hypertensive activity of
norepinephrine.
The present studies were designed to evaluate the poten-
tial anti-inflammatory activities of these compounds, in
vivo, on carrageenin-induced paw oedema and pleurisy in
rats. This latter inflammatory reaction allowed us to exam-
ine the influence of PACs not only on the exudate volume
and polymorphonuclear cell accumulation but also on
the release of several cytokines, IL-1β, TNF-α, IL-6, IL-10,
CINC-1 and of nitric oxide (NO). These cytokines and NO
are among the more important mediators involved in
inflammatory processes [14-16].
Results
Influence of PACs on rat paw oedema
Carrageenin-induced oedema was significantly inhibited
by PACs dose-dependently (Figure 2). This inhibitory
effect was efficient from 2 h after the carrageenin injection
for the two upper doses of PACs and was significative 4 h
after the carrageenin administration for all doses of PACs.
The maximum inhibitory effect of PACs reached 63% at 4
h after carrageenin, time of the maximum development of
the oedema.
Influence of PACs on the carrageenin-induced pleurisy
In control rats, the volume of the exudate collected 4 h
after carrageenin injection reached 0.87 ± 0.18 ml per rat
(n = 12). This exudate contained a large number of cells,
mostly (> 95%) polymorphonuclear leukocytes (PMNs).
The total leukocytes number in the exudate was 119.71 ±
29.29 × 106 per rat (Figure 3A). PACs significantly reduced
the volume of the exudate in a dose-dependent relation-
ship, showing a maximum inhibitory effect (48%) from
the dose of 30 mg/kg which was not increased by the
upper doses of PACs. As expected, the volume of the exu-
date was reduced in indomethacin-treated rats. On the
Chemical structure of proanthocyanidins Figure 1
Chemical structure of proanthocyanidins. Where R = H, it is a procyanidin: catechin (R1 = H and R2 = OH) and epicate-
chin (R1 = OH and R2 = H); Where R = OH, it is a prodelphinidin: gallocatechin (R1 = H and R2 = OH) and epigallocatechin (R1 
= OH and R2 = H).BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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other hand, PMNs infiltration (Figure 3B) was signifi-
cantly inhibited by PACs in a dose-dependent way and by
indomethacin.
Effects of PACs on the release of cytokines
High levels of TNF-α, IL-1β, IL-6, IL-10 and CINC-1 were
found in pleural exudates induced by carrageenin (Figure
4). Indomethacin reduced the level of the five cytokines
studied while PACs lowered significatively the levels of
TNF-α (Figure 4A), inhibited the release of IL-1β (Figure
4B) but did not affect IL-6 levels (Figure 4C) and IL-10
production (Figure 4D). PACs also lowered significantly
CINC-1 levels (Figure 4E).
Effect of PACs on nitrite/nitrate (NOx) levels in pleural 
exudate
The pleural exudate of carrageenin-treated rats contained
a large amount of NOx (716 ± 32 µM; n = 6) (Figure 5).
The amount of NOx in pleural exudate of rats treated with
10 mg/kg indomethacin was similar to the content found
in the control group. On the other hand, PACs, at 30 mg/
kg, significantly decreased the amounts of NOx in pleural
exudate from 51%.
Histological examination of lung sections
Histological examination of lung sections revealed signif-
icant tissue injury (Figure 6) when compared with lung
sections taken from saline-treated rats (Figure 6A). Lung
withdrawn from rats treated with carrageenin showed
oedema, tissue injury and an extensive infiltration of the
tissue by PMNs (Figure 6B). Pretreatment of rats with
indomethacin (10 mg/kg, i.p.) or PACs (30 mg/kg, i.p.)
showed a reduced lung injury as well as a decrease in the
infiltration of PMNs (Figures 6C,6D).
Discussion
Proanthocyanidins (PACs) from Ribes nigrum leaves
reduced the inflammatory reactions induced by carra-
geenin in rats : the extent of the paw oedema was halved,
the volume of the pleural exudates and its content in TNF-
α, IL-1β, CINC-1 and NOx were reduced, the infiltration
of leukocytes into the lungs and the accumulation of leu-
kocytes into the pleural cavity were largely diminished.
PACs have been reported to be able to scavenge free radi-
cals and NO [17]. This property could be an explanation
of the reduction of NOx level in the pleural fluid after
PACs treatment. According to Ialenti et al [18], during the
development of carrageenin-induced pleurisy, the main
role of NO is the inhibition of leukocytes migration to the
Time course of inflammatory reaction induced by injection of carrageenin 1% in rat hind paw and its antagonism by PACs (10,  30, 60 and 100 mg/kg-1) Figure 2
Time course of inflammatory reaction induced by injection of carrageenin 1% in rat hind paw and its antago-
nism by PACs (10, 30, 60 and 100 mg/kg-1). Inflammation is expressed as the increase of the rat paw volume (ml) from 0 
to 4 h following injection of carrageenin. The volume of the paw was reduced by PACs at the four doses tested and the inhibi-
tion is time and dose-dependant. Each value is the mean ± s.e. mean of n = 6 experiments. *P < 0.05 versus carrageenin.BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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inflammatory site. However, in rats pretreated with PACs,
the level of NOx and of leukocytes are simultaneously
reduced. This result suggests that PACs could more or less
directly affect the transmigration of leukocytes.
The development of carrageenin-induced inflammatory
reactions in rats results from the activation of the kinin
system, the accumulation of leukocytes and the release of
several mediators such as prostanoids and cytokines
[19,20]. Indeed, these inflammatory reactions are greatly
reduced in kininogen-deficient rats, in animals pretreated
with kinin-antagonists and in leucopenic rats [19,21]. Pre-
vious studies [22] have demonstrated that PACs can
reduce other inflammatory reactions such as the oedemas
induced in rats by nystatin and concanavalin-A in which
the kinin system is not involved [19] but in which leuko-
cytes play a major role [23]. The comparison of the major
determinants of these three kinds of reactions, all inhib-
ited by PACs, is another argument suggesting that the
main target explaining the anti-inflammatory activity of
PACs would be the involvement of leukocytes.
Pro-inflammatory cytokines TNF-α, IL-1β and IL-6 are
sequentially released in the pleural exudates induced by
carrageenin in rat [14]. These cytokines cause chemotaxis
to attract granulocytes and monocytes and then, migrat-
ing leukocytes produce, in turn, further cytokines, such as
TNF-α and IL-1β, and other pro-inflammatory mediators
[15]. IL-6 has been proposed as a crucial mediator for the
development of carrageenin-induced pleurisy and for the
Effect of indomethacin and PACs on carrageenin-induced pleurisy Figure 3
Effect of indomethacin and PACs on carrageenin-induced pleurisy. At 4 h after carrageenin injection, the volume of 
the exudate (A) was reduced by PACs (10, 30, 60 and 100 mg/kg) and indomethacin (10 mg/kg) administration. The accumula-
tion of polymorphonuclear cells (PMNs, B) in the pleural cavity was inhibited by all tested drugs. Each value is the mean ± s.e. 
mean of n = 6 experiments. °P < 0.05 versus sham. *P < 0.05 versus carrageenin.BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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Effect of indomethacin and PACs on cytokines release in pleural exudate Figure 4
Effect of indomethacin and PACs on cytokines release in pleural exudate. Pleural injection of carrageenin caused by 
4 h an increase in the release of the cytokines, tumor necrosis factor alpha (TNF-α, A), interleukin-1β (IL-1β, B), interleukin-6 
(IL-6, C), interleukin-10 (IL-10, D) and cytokine-induced neutrophil chemoattractant-1 (CINC-1, E). TNF-α, IL-1β and CINC-1 
levels were reduced by PACs, but IL-6 and IL-10 levels were not modified. Indomethacin lowered the level of all these 
cytokines. Each value is the mean ± s.e. mean of n = 6 experiments. °P < 0.05 versus sham. *P < 0.05 versus carrageenin.BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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accumulation of leukocytes in the inflammatory site.
Indeed, in carrageenin-induced pleurisy in IL-6 knock-out
mice, the degree of plasma exudation, leukocyte migra-
tion and the release of TNF-α and IL-1β were greatly
reduced. Moreover, a positive feedback plays an impor-
tant part in the development of the oedema as levels of
TNF-α and IL-1β are attenuated in IL-6 knock-out mice
[24]. PACs did not affect the level of IL-6 and of IL-10, an
anti-inflammatory cytokine, but reduced the pleural con-
tent of TNF-α, IL-1β and leukocytes. This result indicates
that the release of IL-6 does not depend on the presence of
leukocytes, of TNF-α and IL-1β on one hand, and, on the
other hand, suggest that the main target of PACs would be
the accumulation of leukocytes and the associated release
of inflammatory mediators.
TNF-α plays an important role in promoting and amplify-
ing lung inflammation through the release of chemotactic
factors such as CINC-1 (rat IL-8), an important mediator
that promotes the migration of neutrophils [25] and oes-
inophils [26]. CINC-1 can increase the expression of LFA-
1 integrin on rat neutrophils [27] and because expression
of leukocyte adhesion molecules such as E-selectin is
dependent on CINC [28], the inhibition of CINC-1 levels
in pleural exudates by PACs may exert both direct and
indirect effects on neutrophil vascular adhesion and
extravascular migration. PACs probably acts by disrupting
TNF-α, IL-1β, CINC-1 and PMNs accumulation pathways.
One of the mechanism for the anti-inflammatory effect of
PACs may be attenuation of the migration of PMNs in the
exudate, because CINC-1, a representative cytokine for
PMNs migration in rats, is suppressed by PACs in parallel
with PMNs number dose-related fashion. Although, clari-
fication for the precise mechanism would remain in
future study.
Recently, grape seed proanthocyanidins have been dem-
onstrated to reduce the expression of soluble adhesion
molecules, ICAM-1, VCAM-1 and E-selectin in the plasma
of systemic sclerosis patients [29]. The same compounds
have been shown to inhibit TNF-α-induced V-CAM-1
expression in human umbilical vein endothelial cells
cultures [30]. A possible mechanism of the anti-inflam-
matory effect of PACs would be an interference with the
expression or the effect of adhesion molecules. This inter-
ference would result in a reduction of polymorphonuclear
cell migration and subsequently in a reduction of the
release of pro-inflammatory factors such as TNF-α and IL-
1β.
Injection of carrageenin into the pleural cavity induces the
accumulation of leukocytes, a release of cytokines, the
expression of inducible NO synthase and of cyclo-oxyge-
nase-2, and thus the release of large amounts of nitric
oxide and of prostanoids [16]. The inhibitory effect of
PACs on the accumulation of leukocytes and on the
release of TNF-α and IL-1β could have resulted in a
decrease in the induction of inducible NO-synthase and
of cyclo-oxygenase-2 and finally of plasma exudation.
Comparatively, some animals have been treated with
indomethacin. The inhibitory effect of this well-known
non-steroidal anti-inflammatory drug is larger than that
obtained with PACs. Indomethacin greatly reduced
plasma exudation, nearly suppressed the accumulation of
leukocytes and decreased the levels of the cytokines while,
it did not modify the pleural content of NOx. Indometh-
acin is known to inhibit the cyclooxygenase-1 and -2
responsible of the release of PGE2 production. The peak of
cyclooxygenase-2 activity measured by prostanoid levels
in carrageenin-induced pleural exudates spreads from 2 to
6 h after irritant injection [31,32]. Both IL-6 and IL-10
release are, in part, stimulated by PGE2 [33,34]. An inhibi-
tion of PGE2 production by high doses of indomethacin
could result in a downregulation of IL-6 and IL-10 pro-
duction [35,36]. Moreover, Cuzzocrea et al [24], using car-
rageenin-induced pleurisy in IL-6 knock out mice, showed
that IL-1β and TNF-α production in the pleural exudates
is, at least, partly IL-6 dependent. Our results showing a
Effect of PACs and indomethacin on NOx formation in pleu- ral exudate Figure 5
Effect of PACs and indomethacin on NOx formation 
in pleural exudate. Production of NOx release was not 
significantly affected by pretreatment of rats with indometh-
acin (10 mg/kg, intraperitoneally) while PACs caused an inhi-
bition in NOx production. Each value is the mean ± s.e. mean 
of n = 6 experiments. °P < 0.05 versus sham. *P < 0.05 versus 
carrageenin.BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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reduction in the levels of IL-1β, TNF-α, IL-6, IL-10 and
CINC-1 by indomethacin four hours after the induction
of the pleurisy, could be mainly explained through the
inhibition of PGE2 and IL-6 pathways.
Conclusions
In conclusion, we have shown that proanthocyanidins
isolated from Ribes nigrum leaves interfere with the accu-
mulation of circulating leukocytes, associated with a
reduction of pro-inflammatory factors such as TNF-α, IL-
1β and CINC-1, a decrease of NOx level and a decrease in
plasma exudation.
Methods
Animals
We used male Wistar rats, weighing 250 – 300 gm. The
animals were maintained on a standard laboratory diet
with free access to water. The experiments were conducted
as approved by the Animal Ethics Committee of the Uni-
versity of Liège, Belgium.
Paw oedema
Rats were pretreated with an intraperitoneal administra-
tion of saline or PACs (10, 30, 60 and 100 mg/kg). Thirty
minutes later, lambda carrageenin, (0.1 ml, 10 mg/ml)
was injected into the plantar region of the right hind paw.
Each experimental group contained six animals. Paw vol-
ume was measured using a water plethysmometer (Ugo
Basile) before and 1 h, 2 h and 4 h after the injection of
carrageenin. After 4 h, the animals were anaesthetized
with a large dose of sodium pentobarbital (80 mg/kg).
Effect of PACs on lung injury Figure 6
Effect of PACs on lung injury. When compared to lung sections taken from control animals (A), lung sections from carra-
geenin-treated rats (B) demonstrated interstitial haemorrhage and polymorphonuclear leukocyte accumulation. Lung sections 
from a carrageenin-treated rat that had received PACs (30 mg/kg) (C) or indomethacin (10 mg/kg) (D) exhibited reduced 
interstitial haemorraghe and a lesser cellular infiltration. Original magnification: × 125.BMC Pharmacology 2004, 4:25 http://www.biomedcentral.com/1471-2210/4/25
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Carrageenin-induced pleurisy
Rats were pretreated with an intraperitoneal injection of
saline, PACs (10, 30, 60 or 100 mg/kg) or indomethacin
(10 mg/kg) 30 min before the intrapleural injection of the
irritant. They were then anaesthetized with ketamine HCl
(75 mg/kg) and carrageenin (0.2 ml, 10 mg/ml) or saline
(0.2 ml) was administered into the right pleural cavity.
Each experimental group contained 6 animals. Four hours
later, the animals were anaesthetized with sodium pento-
barbital (80 mg/kg). The chest was carefully opened and
the pleural cavity rinsed with 2.0 ml saline solution con-
taining heparin (5 U/ml). Exudates and washing solutions
were removed by aspiration and the total volume meas-
ured. Exudates with blood were rejected. Exudates were
aliquoted and kept frozen at -32°C.
After removal of the exudates, lungs were withdrawn and
fixed for one week under 30 cm pressure with 10% for-
maldehyde aqueous solution containing 0.480 M
Na2HPO4 and 0.187 M KH2PO4 (pH 7.2) at room temper-
ature. They were then dehydrated by graded ethanol and
embedded in Paraplast. Tissue sections (thickness 7 µm)
were deparaffinized with UltraClear, stained with hema-
toxylin-eosine and examined using light microscopy.
The volume of the exudates was calculated by subtracting
the volume of the washing solution (2.0 ml) from the
total volume recovered. A sample of each exudate was
diluted in phosphate buffer and total leukocyte count was
performed using a hemocytometer.
The levels of IL-1β, TNF-α, IL-6 and IL-10 in the exudates
were measured using a colorimetric commercial ELISA kit
(Biosource, Nivelles, Belgium) with a lower detection
limit of 4, 3, 8 and 5 pg/ml, respectively. The levels of
CINC-1 in the exudates were measured using a colorimet-
ric commercial ELISA kit (Amersham Biosciences,
Freiburg, Germany) with a lower detection limit of 0.49
pg/ml.
The amount of NOx (nitrite/nitrate) present in the exu-
dates was determined using a microplate assay method
(Calbiochem, Leuven, Belgium) based on Griess reaction
after reduction of NO3 
- to NO2 
- with a lower detection
limit of 1 µM.
Extraction and purification of proanthocyanidins
Proanthocyanidins from Ribes nigrum leaves were
extracted and isolated according to a previously described
method [37]. A voucher sample (RN 210590) has been
deposited in the Pharmaceutical Institute of Liège, Bel-
gium. Briefly, leaves were powdered separately and then
extracted at room temperature with acetone (70 % v/v in
water). The acetone was removed under vacuum at 40°C.
The resulting aqueous solution was freeze-dried. Isolation
was carried out by MPLC on reversed-phase RP8 with
water-acetone (9:1) to obtain a total proanthocyanidin-
enriched fraction (PACs).
Materials
We used ketamine-HCl from Pfizer (Bruxelles, Belgium),
sodium pentobarbital from Ceva (Bruxelles, Belgium)
and heparin from B. Braun Medicals (Diegem, Belgium).
PACs and lambda carrageenin (Sigma, Bornem, Belgium)
were dissolved in saline. Indomethacin (Merck, Sharp and
Dohme, Leuven, Belgium) was dissolved in Tris-HCl
(0.15 M, pH 7.4).
Statistical evaluation
Results are given as mean ± standard error of the mean
(s.e. mean) of N observations. For the oedema paw stud-
ies, a Mixed Procedure SAS (normal distribution) was
used to compare difference of least square means. For the
pleurisy studies, data sets were examined by one-way
analysis of variance (ANOVA) followed by a Scheffe post-
hoc test. A P-value of less than 0.05 was considered
significant.
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